Zhejiang Communications Technology (002061.SZ) proposes to issue shares to the original shareholders and the authorized period will expire and become invalid.
Zhejiang Jiaokete (002061.SZ) announcement, according to previous announcement, the company will hold the eighth... on August 23, 2023.
Zhejiang Communications Technology (002061.SZ) announcement, according to a previous announcement, the company held the 25th meeting of the eighth board of directors and the 21st meeting of the eighth board of supervisors on August 23, 2023, and the second extraordinary general meeting of shareholders in 2023 on September 22, 2023, and reviewed and approved the "Proposal on the Company's Issuance of Shares to Original Shareholders" and the "Proposal on Seeking Shareholders' Authorization for the Board of Directors or Authorized Persons to Handle Matters related to the Rights Issue."
Since the disclosure of the rights issue plan, the company has been actively promoting related work with intermediaries. Due to the comprehensive impact of changes in the capital market financing environment and the actual situation of the company, the company has not been able to complete the rights issue and authorization matters within the validity period of the rights issue plan. As of September 21, 2024, the validity period of the rights issue plan and authorization matters has been 12 months from the date of approval by the shareholders' meeting, and will automatically expire after the expiration date.
Related Articles

US Stock Market Move | Mexican airline (AERO.US) landed on the US stock market and opened with a rise of more than 2.8%.

US Stock Market Move | Biopharmaceutical company Evommune (EVMN.US) debuts on the US stock market with a stock price surge of over 15%.

US Stock Market Move | BEIGENE (ONC.US) rose more than 3% with third-quarter revenue breaking 10 billion and raising its 2025 performance guidance.
US Stock Market Move | Mexican airline (AERO.US) landed on the US stock market and opened with a rise of more than 2.8%.

US Stock Market Move | Biopharmaceutical company Evommune (EVMN.US) debuts on the US stock market with a stock price surge of over 15%.

US Stock Market Move | BEIGENE (ONC.US) rose more than 3% with third-quarter revenue breaking 10 billion and raising its 2025 performance guidance.

RECOMMEND

SERES Faces Market Test in Hong Kong: Shares Open Below Issue Price Despite HK$220 Billion Market Valuation
06/11/2025

Copper Prices Surge While Former “Copper King” Who Outpaced Huawei and Tencent Falls into Decline
06/11/2025

National Energy Administration Reports New-Type Energy Storage Capacity Exceeds 100 Million Kilowatts by End‑September
06/11/2025


